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Summary
Squamous cell carcinoma of uterine cervix is potentially
a curable disease; however, many patients treated with
definitive chemoradiotherapy develop distant metastases,
with few of them having a single metastatic deposit.
There are no guidelines for the treatment of patients with
oligometastatic cervical cancer.
We present a case of a patient with International
Federation of Gynecology and Obstetrics (FIGO) Stage
IIB squamous cell carcinoma of uterine cervix. She was
successfully treated with concurrent chemoradiotherapy
with definitive intent. One year later, she developed a
solitary pulmonary nodule for which she underwent
resection followed by chemotherapy. She is free of any
local or distant disease at 5 years of regular follow-up.

Background
Cervical cancer is the fourth most common malignancy among women in developing countries and
majority of them are diagnosed in advanced stage,
beyond surgical treatment.1 There has been a considerable improvement in long-term survival of patients
with locally advanced cervical cancer.2 3 However,
still there is a large proportion of patients who
develop distant metastases, and few of them present
with an oligometastatic disease. There are no guidelines for such patients. If treated aggressively, a small
proportion of patients can still be cured. We present
a case of a woman, who completed treatment with
chemoradiotherapy and later on developed a solitary
right lung base metastasis.

Case presentation
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A 54-year-old woman, known asthmatic, mother
of 3 children, presented with postmenopausal
vaginal bleeding in July 2010. There was no
fever, itching or any history of contraceptive
or antibiotic use. She had insignificant family
history. Vaginal examination showed a barrelshaped cervix, vaginal fornices were obliterated
and shallow and a nodule was palpable in the left
parametrium.
Considering the clinical findings, it was planned
to examine the patient under anaesthesia (EUA). On
EUA, a friable growth coming out of cervix was seen,
a hysteroscope was introduced simultaneously which
revealed cervix and uterus filled with growth. Curettage was performed and friable pieces of growth were
obtained and sent for histopathology.
Sections from endocervical curettings revealed a
tumour composed of sheets and groups of squamous

epithelial cells, having large round to oval nuclei
with prominent nucleoli showing pleomorphism
and hyperchromasia. The cytoplasm was eosinophilic, forming intercellular bridges. Tumour was
infiltrating into the muscle tissue. Scattered chronic
inflammatory cells were seen. On immunohistochemical staining, the tumour cells show positivity
for cytokeratin 5/6 and p16 (figure 1A,B).
Metastatic workup was negative for any distant
disease. She was staged as International Federation
of Gynecology and Obstetrics (FIGO) IIB, grade
III squamous cell carcinoma cervix for which she
was treated with pelvic radiotherapy and concurrent cisplatin chemotherapy (40 mg/m2). Pelvic
radiation consisted of a dose of 45 Gy in 25 fractions via external beam radiation therapy followed
by 3 sessions of high-dose rate intracavitary
brachytherapy. At the end of treatment, the cervical
mass had disappeared. On her first post-treatment follow-up in December 2010, there was no
evidence of local disease on clinical examination,
and CT scan of chest, abdomen and pelvis was also
negative for any locoregional or distant disease.
She was on regular follow-up and in June 2011
on routine follow-up CT scan of chest, abdomen
and pelvis, there was a 3×3 cm nodule in right
lung base (figure 2). The case was discussed in
multidisciplinary team meeting and recommended
to undergo right lower lobectomy for solitary lung
lesion. Histopathology was consistent with poorly
differentiated metastatic carcinoma (figure 3A,B).
After surgery, she was given six cycles of carboplatin (area under curve (AUC) 6) and paclitaxel
(175 mg/m2) chemotherapy, which she completed
in November 2011.

Outcome and follow-up

The patient visited the clinics regularly where
local examination was done every 3 months along
with an annual CT chest, abdomen and pelvis.
After 5 years of surveillance, she is free of any
disease on examination and on imaging.

Discussion

Pulmonary metastasectomy is a recognised therapeutic
modality for the treatment of metastatic disease.
Surgical resections have been widely performed on
patients with pulmonary metastasis from soft tissue
sarcoma and colorectal cancer. However, the role of
metastasectomy in metastatic squamous cell carcinoma
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Figure 1 (A) H&E staining shows an infiltrating tumour arranged in
nests with overlying endocervical columnar lining (B) Tumour cells are
positive for p16 immunohistochemical stain.
of uterine cervix is not well explored. There are currently no standard surgical options for pulmonary metastasis.
Okiror et al showed that pulmonary metastasectomy confers
an improved survival in patients with metastatic sarcoma. A
total of 80 pulmonary metastasectomies were performed on
66 patients. The median number of metastases resected was
three, and there were no postoperative in-hospital deaths. The
median overall survival (OS) was 25.5 months; however, recurrence of metastases significantly affected survival.4
Historically, the clinical practices with respect to colorectal
cancers have been reviewed thoroughly focusing on the detection
of lung and liver metastasis and their subsequent resections.5 In a
retrospective study, Hattori et al evaluated outcomes after pulmonary resection of colorectal metastases in patients with or without a
curative hepatic metastasectomy. The 5-year OS of the lung metastasectomy group was significantly better than that of the liver and lung
metastasectomy group.6 Similarly, a Japanese study showed that
surgical resection offers a chance to prolong survival in colorectal
cancer patients with resectable pulmonary metastases.7
Apart from sarcomas and adenocarcinomas, the role of metastasectomy in metastatic squamous cell carcinoma is not well
established. A systematic review of studies examining outcomes
for patients with head and neck squamous cell carcinoma who
underwent pulmonary metastasectomy for metachronous pulmonary metastases was conducted in the UK, but it only provided
limited evidence in the favour of pulmonary metastasectomy.8
Little is known about the long-term survival after pulmonary
metastasectomy for gynaecological malignancies. Tumour histopathology, duration of disease-free interval after the treatment
of primary site, number of pulmonary metastases and absence
of extra pulmonary disease have been identified as independent prognostic factors in the management of metastatic gynaecological malignancies.9 10 There are few single institutional
reports highlighting this subject. Adachi et al reported a 5-year
OS of 81.7% in 37 patients with isolated lung metastases (<3
nodules). The histopathology of gynaecological tumours was not
mentioned in this study.11

Figure 3 (A) Metastatic squamous cell carcinoma to lung filling the
alveoli. (B) Tumour cells showing nuclear positivity for p16 immunostain.
A retrospective analysis of 103 patients conducted at Mayo
Clinic showed that pulmonary resection for metastatic gynaecological cancer in selected patients is safe and effective. However, the
majority of the patients had disease in uterine corpus, while cervix
was involved in only seven. Furthermore, merely five patients had
disease with squamous cell histology.12 A study by Anraku et al
stratified the 5-year OS for each histological type. Squamous cell
carcinomas of cervix had better 5-year OS when compared with
cervical adenocarcinomas. The same study showed that patients
with a disease-free interval of 12 months or more are good candidates for metastasectomy, provided there is adequate control of the
primary tumour without extra pulmonary metastasis.9
Our patient was found to have a solitary metastatic nodule in
lung on routine follow-up and systemic investigations. Considering
her good performance status, she was offered metastasectomy.
Anticipating the presence of microscopic disease elsewhere based
on biopsy-proven metastasis in lung, she was given postoperative
chemotherapy consisting of carboplatin at a dose of AUC 6 and
paclitaxel at doses of 175 mg/m2 every three weeks. She tolerated this treatment uneventfully and is disease free after 5 years of
treatment. However, there is no data in the contemporary literature emphasising the significance of adjuvant chemotherapy after
metastasectomy.
The largest report to date, a multi-institutional study including
cervical cancer patients exclusively, reported a 5-year disease-free
survival (DFS) rate of 32.9% after pulmonary metastasectomy.
Patients with one or two pulmonary metastases had a 5-year DFS
rate of 42.2% compared with 0% for patients with three or four
metastases. Patients with squamous cell cancers had a 5-year DFS
rate of 47.4%, compared with 0% for patients with adenosquamous cell cancers or adenocarcinoma.10
These existing reports on the role of metastasectomy in
cases of squamous cell carcinoma of cervix with oligometastatic disease emphasise the need for an aggressive treatment
approach, considering it as potentially a curative treatment.
However, there is a swift need for multicenter collaboration that
will establish the clinical guidelines for the better management
of such patients.

Learning points
►► International Federation of Gynecology and Obstetrics (FIGO)

Figure 2
2

Axial CT scan showing right lung base nodule.

stage IV B squamous cell carcinoma of uterine cervix with
solitary metastasis can be approached aggressively with a
curative intent.
►► Like established therapeutic roles in sarcomas and colorectal
cancer, local treatment of distant metastasis has a probable
role in the management of carcinoma of cervix.
►► Multidisciplinary team care is the key to success.
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